Tetratherix Ltd (TTX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Tetratherix Ltd (TTX) has a cash flow conversion efficiency ratio of -0.186x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-4.53 Million ≈ $-3.21 Million USD) by net assets (AU$24.37 Million ≈ $17.24 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Tetratherix Ltd market cap and net worth for the company's overall valuation and market capitalisation.
Tetratherix Ltd - Cash Flow Conversion Efficiency Trend (2023–2025)
This chart illustrates how Tetratherix Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Tetratherix Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Tetratherix Ltd ranked by their cash flow conversion efficiency. See Tetratherix Ltd cash debt coverage ratio to evaluate how effectively operating cash flow covers total debt obligations.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jeju Air Co Ltd
KO:089590
|
0.262x |
|
Kardemir Karabuk Demir Celik Sanayi ve Ticaret AS Class A
IS:KRDMA
|
0.031x |
|
Investar Holding Corp
NASDAQ:ISTR
|
0.023x |
|
Waffer Technology Corp
TW:6235
|
0.027x |
|
Astarta Holding N.V.
WAR:AST
|
0.026x |
|
SITKA GOLD CORP
F:1RF
|
-0.073x |
|
Pacific Current Group Ltd
AU:PAC
|
0.026x |
|
Jantsa Jant Sanayi ve Ticaret AS
IS:JANTS
|
0.132x |
Annual Cash Flow Conversion Efficiency for Tetratherix Ltd (2023–2025)
The table below shows the annual cash flow conversion efficiency of Tetratherix Ltd from 2023 to 2025. View Tetratherix Ltd (TTX) stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$27.25 Million ≈ $19.28 Million |
AU$-2.67 Million ≈ $-1.89 Million |
-0.098x | -125.96% |
| 2024-06-30 | AU$-6.78 Million ≈ $-4.80 Million |
AU$-2.56 Million ≈ $-1.81 Million |
0.378x | +343.15% |
| 2023-06-30 | AU$-4.56 Million ≈ $-3.22 Million |
AU$-388.24K ≈ $-274.70K |
0.085x | -- |
About Tetratherix Ltd
Tetratherix Limited engages in biomaterial and regenerative medicine business in Australia and internationally. The company manufactures and commercialize medical device in the areas of bone regeneration, tissue spacing, and tissue healing applications through its Tetramatrix platform technology. Tetratherix Limited was incorporated in 2015 and is based in Alexandria, Australia.